BCL2 and rheumatoid arthritis: In the present study, we found that TNF-α-treated RA-HFLSs exhibited significantly increased cell viability, number of cell clones, migration rate, number of invasive cells, expression of Bcl-2, and levels of IL-6 and MMP-3, as well as decreased apoptosis rate.